CDK9, a serine/threonine protein kinase of the cyclin-dependent kinase family, regulates transcription by phosphorylating RNA polymerase II and has been implicated in oncogenesis and tumor immune evasion [[14], [15], [16]]. This evidence concerns the gene MARK2 and neoplasm.